Workflow
GF HYDROCOLLOID(01084)
icon
Search documents
绿新亲水胶体(01084) - 2024 - 年度财报
2025-04-29 13:10
願景 使命核心價值 願景 成為全球領先全天然 功能材料(All-Natural Performance Materials) 的研發製造商 使命 與時並進,以質量和創新滿足客戶 不斷發展的應用需求 核心價值 創新、成長、再創新 目 錄 | | 公司資料 | | --- | --- | | 2 | 企業概覽 | | 2 | 經營理念 | | 3 | 集團發展關鍵里程碑 | | 4 | 獎項及榮譽 | | 5 | 財務摘要 | | | 企業回顧 | | 6 | 主席報告 | | 9 | 管理層討論與分析 | | | 企業管治 | | 15 | 董事簡介 | | 18 | 董事會報告 | | 35 | 企業管治報告 | | 47 | 環境、社會及管治報告 | | | 財務報告 | | 122 | 獨立核數師報告 | | | 綜合財務報表 | | 130 | 綜合損益表 | | 131 | 綜合全面收益表 | | 132 | 綜合資產負債表 | | 134 | 綜合權益變動表 | | 135 | 綜合現金流量表 | | 136 | 綜合財務報表附註 | | 206 | 五個年度財務概要 | | 207 | 公司資料 ...
绿新亲水胶体(01084) - 2024 - 年度业绩
2025-03-31 13:49
截至二零二四年十二月三十一日止年度 全年業績 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責,對其準確性或完 整性亦不發表任何聲明,並明確表示,概不就因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致之任何損失承擔任何責任。 GREEN FUTURE FOOD HYDROCOLLOID MARINE SCIENCE COMPANY LIMITED 綠新親水膠體海洋科技有限公司 (於開曼群島註冊成立的有限公司) (股份代號:01084) 董事會欣然宣佈本集團二零二四財年經審核綜合財務業績如下: 董事就截至二零二四年十二月三十一日止年度建議派付末期現金股息每股1.2港 仙,惟須待股東於股東週年大會批准方可作實。 – 1 – - 收益人民幣989.3百萬元,較二零二三財年的人民幣1,174.0百萬元下降 15.7%。 - 毛利人民幣222.5百萬元,毛利率22.5%,較二零二三財年的人民幣37.6百萬 元及3.2%分別增加人民幣184.9百萬元及上升19.3個百分點。 - 二零二四財年的溢利人民幣60.9百萬元,淨利潤率6.1%,較二零二三財年的 淨虧損人民幣85.4百萬元及淨虧損率7 ...
绿新亲水胶体(01084) - 2024 - 中期财报
2024-09-30 09:27
Financial Performance - The company's revenue for the first half of 2024 was RMB 459.0 million, a decrease of 21.2% compared to RMB 582.9 million in the same period of 2023[7]. - In the first half of 2024, the company's gross profit was RMB 98.8 million, a decrease of RMB 7.3 million or 6.9% compared to the first half of 2023[5]. - The overall gross margin for the first half of 2024 was 21.5%, an increase of 3.3 percentage points from the first half of 2023[5]. - The profit attributable to the owners of the company for the first half of 2024 was RMB 231 million, down RMB 19 million or 7.6% from RMB 250 million in the same period of 2023[22]. - The net profit for the period was RMB 22,624,000, compared to RMB 25,116,000 in the previous year, a decrease of 9.9%[38]. - The company reported a basic and diluted earnings per share of RMB 0.028, unchanged from the previous year[38]. - The company's interim profit for the six months ended June 30, 2024, was RMB 22,624,000, a decrease of 9.9% compared to RMB 25,116,000 for the same period in 2023[39]. - Total comprehensive income for the period was RMB 20,534,000, down from RMB 21,503,000 in the previous year, reflecting a decline of 4.5%[39]. Sales and Market Performance - Sales revenue from agar and carrageenan products accounted for 78.8% of total sales revenue, a decrease of 6.6% compared to the first half of 2023[7]. - Sales revenue from carrageenan decreased by RMB 141.3 million or 39.5% in the first half of 2024, primarily due to a drop in seaweed material prices[13]. - The sales value from the Chinese market accounted for 53.6% of total sales, while the overseas market accounted for 46.4%, with respective sales values of RMB 245.9 million and RMB 213.1 million[5]. - The company anticipates a recovery in global demand for hydrophilic colloid products in the foreseeable future due to reduced inventory levels among customers[5]. - The economic conditions in China and European countries remain weak, impacting overall market demand for the company's products[7]. Cost and Expenses - The sales cost for the first half of 2024 was RMB 360.2 million, a reduction of RMB 116.5 million or 24.4% compared to RMB 476.7 million in the first half of 2023[14]. - Administrative expenses for the first half of 2024 were RMB 491 million, up RMB 36 million or 8.0% from RMB 454 million in the same period last year[18]. - In the first half of 2024, the group's sales and distribution expenses amounted to RMB 94 million, an increase of RMB 9 million or 11.0% compared to the same period in 2023[17]. - The company reported financing costs of RMB 16.7 million for the six months ended June 30, 2024, with financing costs decreasing by RMB 3.0 million or 15.2%[16]. Financing and Cash Flow - Financing costs decreased in the first half of 2024 due to lower procurement prices of seaweed materials and reduced average loan balances in RMB, USD, and HKD[7]. - The company's financing income and costs were RMB 287,000 and RMB 16.7 million respectively, with financing costs decreasing by RMB 3.0 million or 15.2%[16]. - The company’s cash flow from operating activities was impacted by a significant increase in tax payments, which rose by approximately 122% year-over-year[17]. - The total cash and cash equivalents at the end of the period were RMB 64,556 thousand, up from RMB 46,620 thousand at the end of June 2023[17]. Assets and Liabilities - As of June 30, 2024, the group's cash and bank balances reached RMB 646 million, a decrease of RMB 80 million or 11.1% from the end of 2023[23]. - The total assets as of June 30, 2024, amounted to RMB 1,509,240,000, a decrease from RMB 1,543,603,000 at the end of 2023, representing a reduction of 2.2%[40]. - The company's equity attributable to owners increased to RMB 769,274,000 from RMB 745,243,000, reflecting a growth of 3.2%[40]. - Total liabilities decreased to RMB 731,736,000 from RMB 789,491,000, a reduction of 7.3%[41]. - The total bank borrowings amounted to RMB 5,843 million, with RMB 5,251 million due within one year[26]. Research and Development - The company has made progress in developing new applications and end products through its research and development efforts[6]. - The company aims to expand its business into high-tech and commercially attractive compound product markets to meet diverse customer needs[6]. - The company has set long-term goals to provide high-technology products, enhancing its product mix and profitability through continuous investment in R&D[5]. Corporate Governance and Compliance - The audit committee, consisting of three independent non-executive directors, reviewed the unaudited interim results for the first half of 2024[121]. - The company has adopted the corporate governance code and confirmed compliance with its applicable provisions during the first half of 2024, with one exception regarding the separation of the roles of chairman and CEO[119]. - The company has established strict guidelines for securities trading by directors and employees, confirming compliance with these standards during the first half of 2024[120]. Shareholder Information - The ownership structure shows that Mr. Chen Jincong holds a 19.48% equity interest and a 70.87% interest through a concert party agreement, reflecting significant insider ownership[97]. - Major shareholders include Chuangyu and Yingbo, each holding 161,700,000 shares, representing 19.39% of the total shares[99]. - The combined holdings of the concert party agreement amount to 588,000,000 shares, which is 70.49% of the total[99]. Dividend and Share Options - The board did not recommend the distribution of an interim dividend for the first half of 2024[12]. - The company did not propose an interim dividend for 2024, consistent with the decision in 2023[71]. - The company has no options granted, exercised, or canceled under the pre-IPO share option plan as of June 30, 2024[103].
绿新亲水胶体(01084) - 2024 - 中期业绩
2024-08-30 13:35
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責,對其準確性或完 整性亦不發表任何聲明,並明確表示,概不就因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致之任何損失承擔任何責任。 GREEN FUTURE FOOD HYDROCOLLOID MARINE SCIENCE COMPANY LIMITED 綠新親水膠體海洋科技有限公司 (於開曼群島註冊成立的有限公司) (股份代號:1084) 截至二零二四年六月三十日止六個月的 中期業績 | --- | --- | |-------|-------------------------------------------------------------------------| | | | | | 董事會欣然宣佈二零二四年上半年的未經審核簡明綜合中期財務業績如下: | | - | 收益為人民幣 459.0 百萬元,較二零二三年上半年人民幣 582.9 百萬元減少 | | | 21.2% 。 | | - | 毛利為人民幣 98.8 百萬元,毛利率為 21.5% ,較二零二三年上半年的人民幣 | | | 106.1 百萬元及 18.2% ...
绿新亲水胶体(01084) - 2023 - 年度财报
2024-04-26 10:38
Safety and Health Management - In 2023, the company implemented a safety production responsibility system, emphasizing accountability at all levels to enhance safety performance [2]. - The company conducted safety training and inspections, including emergency drills for hazardous chemical leaks and fire evacuations, to improve employee emergency response capabilities [5]. - Over the past three years, the company reported no fatalities due to work-related incidents, with a total of 300 workdays lost due to injuries in the reporting period [6]. - The company provided personal protective equipment such as anti-static clothing and high-pressure gloves to employees engaged in special operations [7]. - The company established a monthly performance evaluation system for production staff to enhance safety performance indicators and address potential safety hazards [2]. - The company organized a "Safety Production Month" in 2023, promoting the concept of "safety first" among employees [3]. - The company adheres to the Occupational Disease Prevention Law, conducting annual health check-ups for employees and maintaining health monitoring files [7]. - The company has implemented a comprehensive safety management system, including regular inspections and emergency response plans for various hazardous operations [2]. - The company actively promotes safety awareness through signage and LED displays in production areas [4]. Employee Management and Training - The total number of employees as of December 31, 2023, is 1,184, all of whom are full-time staff [22]. - The company hired 2 external trainers for specialized training for managerial staff and team leaders in 2023 [14]. - The company has established a comprehensive training management system, including annual and monthly training plans, to enhance employee skills and knowledge [14]. - The company offers various training opportunities, including external training, onboarding for new employees, and management training [14]. - The company aims to cultivate innovative talents and enhance operational efficiency through its training programs [14]. - In 2023, the company conducted 6 employee communication meetings to strengthen the connection between employees and management [29]. - The company emphasizes performance-based management and has optimized its performance evaluation system with four core assessment dimensions [24]. - The company is committed to providing fair treatment to all employees, ensuring compliance with labor laws and regulations [27]. - The company has implemented a "Key Department Talent Pipeline Construction Plan" to match talent with key positions and tailor training programs accordingly [20]. Financial Performance - The group experienced a significant decline in gross profit and gross margin due to a sharp drop in the selling price of carrageenan products, influenced by a substantial decrease in overseas customer demand [70]. - The group recorded an annual net loss for the fiscal year 2023, attributed to high sales costs and rising bank borrowing rates in USD and HKD [70]. - The total revenue for the fiscal year 2023 was RMB 1,174.0 million, a decrease of 16.8% compared to RMB 1,410.9 million in fiscal year 2022 [88]. - The overall gross profit was RMB 180.0 million with a gross margin of 15.3%, down 53.1% and 11.9 percentage points from RMB 384.1 million and 27.2% in fiscal year 2022, respectively [96]. - The sales value from the Chinese market was RMB 595.2 million, an increase of RMB 12.3 million or 2.1%, while the overseas market sales value was RMB 578.8 million, a decrease of RMB 249.2 million or 30.1% [81]. - The company recorded an annual net loss in fiscal year 2023 due to a significant decline in the selling price of carrageenan products and rising bank borrowing rates [79]. - The net loss attributable to the owners of the company was RMB 85.3 million, a decrease of RMB 284.5 million or 142.8% compared to a profit of RMB 199.2 million in fiscal year 2022 [100]. - The cash and bank balances increased by RMB 45.6 million or 117.8% to RMB 84.3 million as of December 31, 2023 [101]. - The current ratio as of December 31, 2023, was 1.43, down from 1.60 as of December 31, 2022 [101]. - The total bank borrowings amounted to RMB 599.1 million, with a weighted average interest rate of 5.73% as of December 31, 2023, compared to 4.59% in the previous year [107]. Corporate Governance and Compliance - The board is responsible for the group's risk management and internal control systems, ensuring their overall effectiveness [35]. - The internal audit department, led by the internal audit manager, conducts reviews of operational, financial, and compliance controls to ensure adherence to risk management policies [36]. - The board reviewed the effectiveness of the risk management and internal control systems and found them to be adequate and effective [37]. - The company has established an insider information disclosure policy to manage and disclose insider information in compliance with regulations [37]. - The company has implemented training for all directors to ensure compliance with listing rules and regulations regarding securities trading [42]. - The company secretary has completed no less than 15 hours of relevant professional training to update skills and knowledge as required by listing rules [43]. - The company's Audit Committee consists of three independent non-executive directors, ensuring compliance with corporate governance standards [189]. - The Nomination Committee reviewed the board's structure and diversity, ensuring appropriate qualifications for board members [191]. - The Remuneration Committee assessed the remuneration of directors and senior management, ensuring transparency in compensation policies [197]. - The company confirmed no significant uncertainties affecting its ability to continue as a going concern [198]. Research and Development - The number of product R&D personnel increased to 80 in 2023, up from 63 in 2022 [58]. - Continuous investment in R&D is aimed at enhancing product offerings, with significant market potential identified for instant agar products and deep-processed carrageenan products [84]. - The group has initiated research and preliminary production of 100% biodegradable seaweed films for plastic alternative packaging and mulch [59]. Shareholder Relations and Dividends - Shareholders have the right to propose independent resolutions at general meetings on significant matters, including the election of individual directors [44]. - The company did not recommend any final dividend for the fiscal year 2023, compared to a final dividend of HKD 0.03 per share for the fiscal year 2022 [143]. - The company’s dividend policy aims to distribute at least 20% of the distributable profit attributable to shareholders, subject to operational needs and future business expansion plans [180]. - The company encourages shareholders to attend the annual general meeting to raise any questions directly to the board and management [178]. - The board has reviewed the implementation and effectiveness of the shareholder communication policy, with satisfactory results [176]. - The company has established a channel for effective communication through its website, where financial information and other relevant data are published [176]. Environmental and Social Responsibility - The company has not recorded any environmental breaches or violations during the fiscal year ending December 31, 2023 [150]. - The company emphasizes the importance of maintaining good relationships with employees, customers, and suppliers to achieve its short-term and long-term goals [149]. - The company has complied with all relevant laws and regulations that significantly impact its business and operations during the review period [151]. - The nature of the company's main business has not undergone significant changes during the year [141].
绿新亲水胶体(01084) - 2023 - 年度业绩
2024-03-27 14:08
Financial Performance - Total revenue for the year ended December 31, 2023, was RMB 1,173,991 thousand, a decrease of 16.8% from RMB 1,410,889 thousand in 2022[2] - Gross profit for the year was RMB 37,641 thousand, significantly down from RMB 384,122 thousand in the previous year[2] - The company reported a net loss of RMB 85,444 thousand for the year, compared to a profit of RMB 199,919 thousand in 2022[2] - Basic and diluted loss per share for the year was RMB (0.103), compared to earnings of RMB 0.242 in the previous year[2] - Total revenue for the fiscal year 2023 was RMB 1,174.0 million, a decrease of 16.8% compared to RMB 1,410.9 million in fiscal year 2022[68] - The loss attributable to the company's owners was RMB 85.3 million, a decrease of RMB 284.5 million or 142.8% compared to a profit of RMB 199.2 million in fiscal year 2022[77] - The company incurred a loss of RMB 85.4 million in fiscal year 2023, with a net loss margin of 7.3%, a decline of 142.7% compared to a profit of RMB 199.9 million and a net profit margin of 14.1% in fiscal year 2022[167] Revenue Breakdown - Revenue from the China segment was RMB 595,174 thousand, a slight increase from RMB 582,922 thousand in 2022[18] - Revenue from the European segment decreased to RMB 291,632 thousand from RMB 470,733 thousand in the previous year, reflecting a decline of 38.0%[18] - Revenue from the China segment was RMB 423,478 thousand in 2023, down from RMB 448,184 thousand in 2022, reflecting a decline of approximately 5.5%[43] - In fiscal year 2023, sales value from the Chinese market accounted for approximately 50.7%, while overseas market sales value accounted for 49.3%, compared to 41.3% and 58.7% in fiscal year 2022[69] - Sales value in the Chinese market was RMB 595.2 million, an increase of RMB 12.3 million or 2.1%, while overseas market sales value decreased by RMB 249.2 million or 30.1% to RMB 578.8 million[69] Inventory and Provisions - The company recognized an inventory provision of RMB 142.4 million to adjust inventory to its net realizable value as of December 31, 2023[9] - The company recognized a provision for inventory write-down amounting to RMB 142,424 thousand in 2023, compared to no provision in 2022[46] - The gross profit margin decreased by 24.0 percentage points to 3.2% due to higher sales costs of carrageenan products, including a provision of RMB 142.4 million for inventory[97] - The group recorded a significant impact of RMB 142.4 million in inventory provisions for carrageenan products based on current market price estimates[102] - Inventory as of December 31, 2023, was RMB 784.998 million, down from RMB 906.209 million in the previous year[169] Assets and Liabilities - Total equity as of December 31, 2023, was RMB 754,112 thousand, down from RMB 852,210 thousand in 2022[4] - The total amount of trade payables decreased to RMB 103,713 thousand in 2023 from RMB 137,763 thousand in 2022, a reduction of approximately 24.7%[65] - The total liabilities of the company as of December 31, 2023, were RMB 789.5 million, compared to RMB 838.8 million in the previous year[164] - Total assets decreased to RMB 1,543.6 million as of December 31, 2023, from RMB 1,691.0 million in the previous year[169] Operational Insights - The company plans to continue focusing on operational cash flow and bank borrowings to meet its working capital needs[9] - The company plans to expand the capacity of PT Hongxin to leverage cost advantages and potential tax benefits in the foreseeable future[72] - The company maintains a focus on product innovation and technical expertise to enhance performance and investment returns despite global economic uncertainties[70] - The group plans to continue investing in capacity expansion at PT Hongxin in 2024 as part of its strategy to enhance cost competitiveness[116] Employee and Governance - Employee benefit expenses increased to RMB 117,866 thousand in 2023 from RMB 110,117 thousand in 2022, reflecting a rise of approximately 7.9%[46] - The group had a total employee cost of RMB 117.9 million in fiscal year 2023, compared to RMB 110.1 million in fiscal year 2022[119] - The company has maintained a good working relationship with employees and offers competitive compensation aligned with market standards[138] - The board of directors has complied with all provisions of the corporate governance code for fiscal year 2023, with one exception regarding the separation of roles of chairman and CEO[125][126] Taxation - The company’s subsidiary in Indonesia is subject to a corporate tax rate of 22%, consistent with the previous year[49] - The company plans to maintain a tax rate of 25% for its subsidiaries in China, consistent with the previous year[194] - The income tax expense for 2023 was RMB (27,447) thousand, a decrease from RMB 61,670 thousand in 2022, marking a reduction of approximately 144.5%[196] Shareholder Information - The company declared a final dividend of 3 HK cents per share in 2023, up from 2.5 HK cents per share in 2022, totaling RMB 22,433 thousand[56] - The company did not recommend any final dividend for fiscal year 2023, compared to a dividend of HKD 0.03 per share in fiscal year 2022[167] - In the fiscal year 2023, the company adopted a share incentive plan, purchasing 544,000 shares at a total cost of approximately HKD 482,000[122] - A total of 860,000 shares were vested under the share incentive plan in fiscal year 2023[122]
绿新亲水胶体(01084) - 2023 - 中期财报
2023-09-19 08:35
胡國華先生 綠 新 親 水 膠 體 海 洋 科 技 有 限 公 司 2 安山工業園 管理層討論與分析 截至截至二零二三年六月三十日止六個月(「二零二三年上半年」),本集團因海外客戶需求週期性減少而受到嚴 重影響,以及由於二零二二年以相對較高的價格採購海藻導致存貨平均成本增加,銷售成本因而上升,從而導 致卡拉膠產品毛利率大幅下降。此外,美元(「美元」)與港元(「港元」)銀行借款利率的持續上升,以及人民幣 (「人民幣」)對美元的貶值,進一步對本集團於二零二三年上半年的經營溢利造成壓力。 於二零二三年上半年,中國及海外市場銷售價值分別佔本集團總銷售價值的50.6%及49.4%(二零二二年上半 年:39.6%及60.4%)。中國市場銷售價值為人民幣294.7百萬元,增加人民幣39.6百萬元或15.5%。海外市場銷 售價值為人民幣288.2百萬元,減少人民幣100.9百萬元或26%,其中售予歐洲國家的產品價值減少人民幣89.5 百萬元或38.3%,主要由於安全庫存標準的調整,加上二零二三年上半年大多數歐洲國家經濟放緩,導致海外客 戶需求減少。 5 管理層討論與分析 本集團在提供具有較高產品技術水平的產品方面設定了長期目 ...
绿新亲水胶体(01084) - 2023 - 中期业绩
2023-08-30 13:15
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責,對其準確性或完 整性亦不發表任何聲明,並明確表示,概不就因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致之任何損失承擔任何責任。 GREEN FUTURE FOOD HYDROCOLLOID MARINE SCIENCE COMPANY LIMITED 綠 新 親 水 膠 體 海 洋 科 技 有 限 公 司 (於開曼群島註冊成立的有限公司) (股份代號:1084) 截 至 二 零 二 三 年 六 月 三 十 日 止 六 個 月 的 中 期 業 績 董事會欣然宣佈二零二三年上半年的未經審核簡明綜合中期財務業績如下: - 收益為人民幣582.9百萬元,較二零二二年上半年人民幣644.2百萬元減少 9.5%。 - 毛利為人民幣106.1百萬元,毛利率為18.2%,較二零二二年上半年的人民幣 195.4百萬元及30.3%分別減少人民幣89.3百萬元及12.1個百分點。 - 二零二三年上半年溢利為人民幣25.1百萬元,淨利率為4.3%,較截至二零 二二年上半年的人民幣104.5百萬元及16.2%分別減少人民幣79.4百萬元及 ...
绿新亲水胶体(01084) - 2022 - 年度财报
2023-04-27 08:31
二零二二年,由於全球大部分地區完全從 COVID-19的影響中恢復過來,同時二零二二年底中國也全面放寬了 COVID-19疫情控制措施,董事預期全球食品需求的長期增長董事十分可觀。 銷售成本 截至二零二二年十二月三十一日止年度,本集團的毛利為 447.5百萬港元(二零二一年:270.4百萬港元),錄得 65.5%的上升。年內整體毛利率為27.2%,相對二零二一年錄得4.0個百分點的上升。卡拉膠的毛利率上升8.0個 百分點,而瓊脂、魔芋及複配產品的毛利率分別下跌3.5個百分點、1.8個百分點及3.4個百分點。受強勁市場需 求推動,卡拉膠的售價因應自二零二一年年底起直至二零二二年的海藻購買價持續上升而不斷攀升。年內,瓊 脂、卡拉膠及複配產品的平均售價分別上升12.7%、67.6%及33.3%,而銷售成本也有不同程度的增加。由於卡 拉膠售價飆升,本集團能夠出售其手頭之前以較低的成本製造的存貨,從而進一步提升其毛利率。值得注意的 是,此亦為本集團基於最新市場情況不時制定的存貨管理戰略的預期結果。 截至二零二二年十二月三十一日止年度,本集團的銷售及分銷開支為16.1百萬港元(二零二一年:16.7百萬港 元),錄得3.6 ...
绿新亲水胶体(01084) - 2022 - 年度业绩
2023-03-30 13:21
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責,對其準確性或完 整性亦不發表任何聲明,並明確表示,概不就因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致之任何損失承擔任何責任。 GREEN FUTURE FOOD HYDROCOLLOID MARINE SCIENCE COMPANY LIMITED 綠 新 親 水 膠 體 海 洋 科 技 有 限 公 司 (於開曼群島註冊成立的有限公司) (股份代號:01084) 截 至 二 零 二 二 年 十 二 月 三 十 一 日 止 年 度 全 年 業 績 董事會欣然宣佈截至二零二二年十二月三十一日止年度的本集團綜合經審核財務 業績如下: - 收益1,643.8百萬港元,較截至二零二一年十二月三十一日止年度1,163.1百 萬港元上升41.3%。 - 毛利447.5百萬港元,毛利率27.2%,較截至二零二一年十二月三十一日止年 度的270.4百萬港元及23.2%分別上升65.5%及4.0個百分點。 ...